Market Place
Sourcing Support
Padagis Invests $36M+ To Expand U.S. Manufacturing
28 Oct 2025 //
PR NEWSWIRE
Zydus Gets Health Canada Approval For Mesalamine Suppositories
27 Oct 2025 //
INDPHARMAPOST
Teva Settles Asthma Inhaler Antitrust Lawsuit For $35M
27 Oct 2025 //
REUTERS
FDA Urges Pharma Companies To Finish Nitrosamine Risk Assessments
27 Oct 2025 //
RAPS
Qilu Pharma Files Abbreviated NDA for Exparel
27 Oct 2025 //
GLOBENEWSWIRE
CF Buyers Club Aims To Grow Access To Vertex`s Trikafta
24 Oct 2025 //
FIERCE PHARMA
Glenmark Pharma USA To Launch Ropivacaine Hydrochloride
24 Oct 2025 //
INDPHARMAPOST
FDA Approves Caplin Steriles` ANDA For Nicardipine Hydrochloride
24 Oct 2025 //
INDPHARMAPOST
Lupin Launches Authorized Generic Of Ravicti In US
24 Oct 2025 //
INDPHARMAPOST
Dr Reddy`s Gets Nod To Make Generic Semaglutide For Weight Loss
24 Oct 2025 //
ECONOMICTIMES
Branded Legacy Advances Intranasal Naloxone Spray With FDA
22 Oct 2025 //
GLOBENEWSWIRE
Pacira Bio Sciences Notified of ANDA Filing from Exparel
21 Oct 2025 //
GLOBENEWSWIRE
High-Quality Data Is Essential for AI Tools for Generic Drugs
21 Oct 2025 //
RAPS
Novo`s Rybelsus Gains FDA Expansion To Reduce Risk Of MACE
21 Oct 2025 //
FIERCE PHARMA
Endo Introduces Sole Generic RAVICTI Oral Liquid in US
20 Oct 2025 //
PR NEWSWIRE
Sunshine Launches STD, Acne & Lyme Disease Therapy Doxycycline
20 Oct 2025 //
PHARMIWEB
FDA Approves Alembic`s Triamcinolone Acetonide Injectable
19 Oct 2025 //
INDPHARMAPOST
Strides and Incepta Partner to Expand Women’s Health Access
17 Oct 2025 //
PRESS RELEASE
Roche`s Appeal Denied By Supreme Court In Risdiplam Generic Drug
17 Oct 2025 //
BUSINESS STD
Sunshine Bio Launches Cholesterol Drug Pravastatin
16 Oct 2025 //
PHARMIWEB
Roche Challenges Natco`s Generic Risdiplam Launch In India
14 Oct 2025 //
ECONOMICTIMES
Aspen Wins Approval to Market Lilly`s Mounjaro in South Africa
13 Oct 2025 //
REUTERS
Moderna Claims Early Victory For Cancer Antigen In Melanoma
13 Oct 2025 //
BIOSPACE
Natco Wins Patent Battle To Launch Generic `Risdiplam`
11 Oct 2025 //
ECONOMICTIMES
Tariff Pause Eases Pressure On Drug Companies
11 Oct 2025 //
ECONOMICTIMES
Trump & Co Halts Generic Drug Tariffs, Boosts Indian Pharma Stock
09 Oct 2025 //
ECONOMICTIMES
Gilead Inks Biktarvy Settlements With 3 Generic Drug Makers
07 Oct 2025 //
FIERCE PHARMA
Biocon Unit Gets USFDA Nod For Genetic Anti-Bacterial Drug
07 Oct 2025 //
ECONOMICTIMES
Pharmanovia Appoints Stephan Eder As CEO
07 Oct 2025 //
INDPHARMAPOST
Zydus Gets Health Canada Approval For Liothyronine Tablets
07 Oct 2025 //
INDPHARMAPOST
Kennedy Push For Autism Drug Gets A Boost From Pharma
06 Oct 2025 //
REUTERS
Zydus Lifesciences Gets USFDA Nod For Deflazacort Oral Suspension
06 Oct 2025 //
ECONOMICTIMES
Supreme Court Rejects Purdue`s Oxycontin Patent Appeal
06 Oct 2025 //
REUTERS
FDA Confirms Para IV Patent Litigation for Korsuva
06 Oct 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Welireg
06 Oct 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Nourianz
06 Oct 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Rezurock
06 Oct 2025 //
FDA
Lupin Launches Liraglutide Injection In US
04 Oct 2025 //
INDPHARMAPOST
FDA Launches Pilot Program to Fast-Track Review of Generic Drugs
03 Oct 2025 //
REUTERS
Alkermes Faces Lawsuit For Blocking Generic Vivitrol
03 Oct 2025 //
REUTERS
Fine, Kaplan And Black Announce Class Action Settlement
03 Oct 2025 //
PR NEWSWIRE
FDA Drafts New Policies To Boost US Drug Production
03 Oct 2025 //
FIERCE PHARMA
FDA Approves Another Generic Version of Abortion Pill
03 Oct 2025 //
REUTERS
Most Americans Back Extending ACA Tax Credits, KFF Poll Shows
03 Oct 2025 //
REUTERS
Pharmather Updates On Ketamine Development And Commercial
02 Oct 2025 //
GLOBENEWSWIRE
Pharmather Sells Ketamine ANDA, Poised For $25M+ In Payments
01 Oct 2025 //
GLOBENEWSWIRE
FDA Lists Its Upcoming Research Priorities For Generic Drugs
01 Oct 2025 //
RAPS
Kexing Bio`s Sorafenib Generic Approved In Egypt & Peru
30 Sep 2025 //
PR NEWSWIRE
Lupin Gets FDA Nod For Rivaroxaban Oral Suspension
30 Sep 2025 //
EXPRESSPHARMA
Nrx Pharma Resubmits ANDA For Ketafree
29 Sep 2025 //
GLOBENEWSWIRE
Indian Pharma Association Hits Back After US Tariff Concerns
29 Sep 2025 //
ECONOMICTIMES
Datanomics: India doubles its share in prescription drugs to US
29 Sep 2025 //
BUSINESS STD
Indian Pharma Likely to Dodge Immediate Impact of Trump`s Tariff
26 Sep 2025 //
BUSINESS STD
TWN Urges Universal $40/year Access To Generic Lenacapavir
26 Sep 2025 //
PHARMABIZ
Lotus Grows US Generics Business With Acquisition Of Alvogen
26 Sep 2025 //
PR NEWSWIRE
Alembic Pharma Receives USFDA Approval For Generic Depression
25 Sep 2025 //
ECONOMICTIMES
Lupin Gets Tentative FDA Nod For Biktarvy Tablets
25 Sep 2025 //
EXPRESSPHARMA
Dr. Reddy`s, Hetero Secure Support to Produce Generic Yeztugo
24 Sep 2025 //
FIERCE PHARMA
Sandoz Introduces Cost-Effective Iron Sucrose Injection
24 Sep 2025 //
BUSINESSWIRE
Bausch, Teva Accused of Delaying Generic Xifaxan
23 Sep 2025 //
REUTERS
